Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy.

Andrew Y C Wong1, Michael G Irwin, Theresa W C Hui

  • 1Department of Anaesthesiology, Queen Mary Hospital, University of Hong Kong, China. ayc_wong@hotmail.com

Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice for "MicroRNA-133b-5p Is Involved in Cardioprotection of Morphine Preconditioning in Rat Cardiomyocytes by Targeting Fas" [Canadian Journal of Cardiology, Volume 32, Issue 8, August 2016, Pages 996-1007. doi:10.1016/j.cjca.2015.10.019].

The Canadian journal of cardiology·2026
Same author

Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53-abnormal Endometrial Carcinomas and Germ Cell Tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Challenges of Real-World Utilization of Recommendations From ClinGen ENIGMA: A Focus on <i>BRCA2</i> Variant Classification in Chinese Population.

JCO precision oncology·2026
Same author

Characterization of Large Genomic Rearrangements in BRCA1 and BRCA2 Genes in a Chinese High-Risk Cohort.

The Journal of molecular diagnostics : JMD·2025
Same author

Ciprofol pharmacology and dosing in various populations.

Expert opinion on pharmacotherapy·2025
Same author

Mortality differences in coronary patients with breast cancer treated with trimetazidine dihydrochloride: potential therapeutic implications.

Cardio-oncology (London, England)·2025

Desmopressin did not reduce blood loss or transfusion needs in partial hepatectomy patients. While it increased clotting factors and improved hemostasis tests, it did not significantly impact surgical outcomes.

Area of Science:

  • Anesthesiology
  • Hepatobiliary Surgery
  • Pharmacology

Background:

  • Elective partial hepatectomy carries risks of significant intraoperative blood loss.
  • Hemostatic management is crucial for patient safety during liver surgery.
  • Desmopressin is known to increase levels of certain coagulation factors.

Purpose of the Study:

  • To evaluate the efficacy of desmopressin in reducing intraoperative blood loss.
  • To assess the impact of desmopressin on coagulation parameters and transfusion requirements.
  • To determine desmopressin's effect on hemostasis during partial hepatectomy.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial was conducted.
  • 59 patients undergoing elective partial hepatectomy were enrolled.

Related Experiment Videos

  • Patients received either desmopressin (0.3 micro g/kg) or normal saline intravenously.

    • Main Results:

    • Desmopressin increased plasma levels of factor VIII and von Willebrand factor in both groups.
    • Activated partial thromboplastin time shortened with desmopressin, while prothrombin time prolonged in the control group.
    • No significant differences in intraoperative blood loss or transfusion requirements were observed between the desmopressin and control groups.

    Conclusions:

    • Desmopressin did not effectively reduce intraoperative blood loss during partial hepatectomy.
    • Transfusion requirements were similar between groups, indicating no significant benefit from desmopressin.
    • Despite improving hemostatic markers, desmopressin failed to translate into reduced bleeding in this surgical context.